FINDEX Inc. (3649) Stock Price

Fine Dex operates three business segments: Medical Business, Public Sector Business, and HealthTech Business. The company develops and sells medical systems and medical devices, while also serving the public sector.

In the Medical Business, Fine Dex provides the integrated viewing system "ClaioDashboard," the image filing system "Claio," and the paper and digital document management system "C-Scan." The company also offers the electronic medical record system "REMORA" and its cloud-based version "REMORA Cloud."

In the Public Sector Business, Fine Dex supplies "DocuMaker Office," a public document management and electronic approval system for local governments, as well as document management systems for medical institution administrative departments. These solutions improve operational efficiency for public agencies and healthcare facilities.

In the HealthTech Business, Fine Dex provides the "GAP-screener," an eye-tracking visual field analyzer for health screening facilities, and "GAP," an eye-tracking visual field analyzer for medical institutions. These products enhance diagnostic and treatment accuracy in clinical settings.

Finedex positions itself with the corporate philosophy of "enriching society through the creation of valuable technology" as its growth strategy. The company prioritizes the rapid development and provision of high-quality solutions that address the needs of healthcare settings and society. Based on new ideas and technological exploration, Finedex advances research and development with the aim of delivering products that exceed customer expectations.

In the healthcare industry, digital technology adoption is advancing, with government-led medical DX projects underway. Finedex pursues additional product adoption by existing customers and acquisition of new customers through active product development and sales. In particular, the company focuses on providing solutions that address regional medical collaboration and physician work style reform.

In the public sector, where competition is limited and DX needs are growing, Finedex is expanding sales of its own products. With strong interest from government organizations and smooth implementation progress, the business environment is favorable. In the healthtech field, Finedex aims to increase awareness of its gaze-analysis visual field analyzer "GAP" and expand sales both domestically and internationally.

Finedex is committed to securing talented personnel to strengthen its business and enhance corporate value. The company prioritizes talent acquisition in development and sales divisions, advancing recruitment to support business expansion. Additionally, Finedex is entering adjacent areas through cloud service development and overseas expansion of medical devices.

Promoting sustainable management is positioned as an important priority. Finedex contributes to building a sustainable society through initiatives toward SDG realization and business activities that consider environmental protection. The company is also strengthening information security measures and providing optimal security solutions to customers.

Furthermore, Finedex positions business reinforcement and expansion through M&A as one of its medium- to long-term management strategies, advancing the selection of effective investment targets and capital allocation. Through these efforts, Finedex aims for sustained growth.